Cyclobenzaprine-13C,d3 hydrochloride

Modify Date: 2024-01-29 10:18:35

Cyclobenzaprine-13C,d3 hydrochloride structure	Common Name	Cyclobenzaprine-13C,d3 hydrochloride
	CAS Number	1261394-10-8	Molecular Weight	315.86
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₉₁₃CH₁₉D₃ClN	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Cyclobenzaprine-13C,d3 hydrochloride

Cyclobenzaprine-13C,d3 (hydrochloride) is the 13C- and deuterium labeled.

Name	Cyclobenzaprine-13C,d3 hydrochloride

Description	Cyclobenzaprine-13C,d3 (hydrochloride) is the 13C- and deuterium labeled.
Related Catalog	Research Areas >> Neurological Disease Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[60].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [2]. Kobayashi, H., Y. Hasegawa, and H. Ono, Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems. Eur J Pharmacol, 1996. 311(1): p. 29-35. [3]. Honda, M., T. Nishida, and H. Ono, Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT(2) receptors. Eur J Pharmacol, 2003. 458(1-2): p. 91-9.

Molecular Formula	C₁₉₁₃CH₁₉D₃ClN
Molecular Weight	315.86